Table 3.
Odds ratio and corresponding 95%CI for HPV types in dual-stain positive compared to dual-stain negative cases and in HIV positive compared to HIV negative cases, (* significant)
| Dual-stain cytology | HIV status | |
|---|---|---|
| HPV 16 | * 13.6 (95%CI 4.8–38.6) | 0,7 (95%CI 0.2–2.3) |
| HPV 18 | * 26.1 (95%CI 5.8–115.9) | 1.2 (95%CI 0.15–9.95) |
| HPV 31 | *8.1 (95%CI 2.1–30.8) | *3 (95%CI 1.1–8.5) |
| HPV 33 | 5,6 (95%CI 0.66–48) | *5.1 (95%CI 1.2–20.8) |
| HPV 35 | 4.1 (95%CI 0.9–19.1) | *5.1 (95%CI 2.1–12.4) |
| HPV 39 | < 0.00 | 3.8 (95%CI 0.99–14.7) |
| HPV 45 | 4.3 (95%CI 0.92–20.1) | 2,7 (95%CI 0.97–7.5) |
| HPV 51 | 2,1 (95%CI 0.3–16.7) | *3 (95%CI 1.1–8.5) |
| HPV 52 | 2.6 (95%CI 0.6–11.18) | *2.4 (95%CI 1.03–5.8) |
| HPV 56 | < 0.00 | < 0.00 |
| HPV 58 | *6.6 (95%CI 1.8–24.9) | 2 (95%CI 0.7–6) |
| HPV 59 | < 0.00 | *4.3 (95%CI 1.1–17.2) |
| HPV 68 | *8 (95%CI 2.7–29.2) | 2.3 (95%CI 0.8–6.3) |